NEW YORK (GenomeWeb News) – Foundation Medicine's revenues through the first half of 2013 increased 363 percent year over year, the company said in its amended Form S-1 on Friday.

The Cambridge, Mass.-based firm, which filed to go public almost three weeks ago, said that revenues through June 30 rose to $11.1 million, compared to $2.4 million during the year-ago period. Net loss for the six months increased to $17.4 million from $11.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.